On 02 March 2017, Pracelo signed an agreement on the co-financing for the implementation of the project entitled: “The production of adipose tissue-derived allogeneic mesenchymal stem cells as compliant with the requirements of Good Manufacturing Practice – an active substance for the investigational medicinal product for advanced-therapy veterinary use, intended for clinical trials in the treatment of degenerative changes of joints and dysplasia in dogs”, within the framework of the Smart Growth Operational Programme 2014-2020, Measure 1.1 “R&D Projects of Enterprises”. The total cost of the project is PLN 4 520 762.90.
The implementation of the project will make it possible to secure a sustainable competitive advantage, which should in turn result in the company gaining a dominant position on the target market.